TAIPEI, Taiwan Jul 5, 2024 – Taiwan Intellectual Property Office has granted ImmunAdd the patent on the preparation of triterpenoid compound. “Innovation for Better Health” We are ImmunAdd.

TAIPEI, Taiwan May 16, 2024 – ImmunAdd, a privately held company developing a fully synthetic saponin-based small molecule, proudly announced that our funder and CEO, Dr. Pi-Hui Liang, awarded “Outstanding Research Award”. Dr. Pi-Hui Liang leads her team, leaning on their erudite knowledge in medical chemistry, drug formulation, and regulations, to work on developing therapies […]

TAIPEI, Taiwan Jan 18, 2024 – IP Australia has granted ImmunAdd the patent on the synthetic saponin molecules. Innovation for Better Health We are ImmunAdd.

TAIPEI, Taiwan Jan 13, 2024 – Canadian Intellectual Property Office has granted ImmunAdd the patent on the synthetic saponin molecules. “Innovation for Better Health” We are ImmunAdd.

TAIPEI, Taiwan Jun 28, 2022 – Taiwan Intellectual Property Office has granted ImmunAdd the patent on the synthetic saponin molecules. Innovation for Better Health We are ImmunAdd.

Our team was awarded the 18th National Award in the Academic Research for “the Discovery of IA05 as a Novel Saponin Adjuvant for Therapeutic Vaccine.” Our proprietary next generation saponin-based adjuvant platform has been awarded in the 18th National Award in the Academic Research.